| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 12.1% | +4.17% | $27.9M | $1.22M | 25.4M | +4.58% | JANUS HENDERSON GROUP PLC | Sep 30, 2025 |
| RA CAPITAL MANAGEMENT, L.P. | 9.9% | $18.6M | 21.3M | RA Capital Management, L.P. | Aug 22, 2025 | |||
| Adimab, LLC | 8.8% | $38.2M | 20.5M | Adimab, LLC | Nov 17, 2025 | |||
| Point72 Asset Management, L.P. | 9.7% | +21.3% | $22.4M | $4.01M | 20.4M | +21.8% | Point72 Asset Management, L.P. | Sep 30, 2025 |
| BIOTECHNOLOGY VALUE FUND L P | 7.4% | $17.6M | 16M | BVF PARTNERS L P/IL | Oct 15, 2025 | |||
| MITHRIL II LP | 4.8% | $12.4M | 11.2M | Mithril II LP | Aug 22, 2025 | |||
| Soleus Private Equity Fund III, L.P. | 5.1% | $11.9M | 10.9M | Soleus Capital Management, L.P. | Oct 10, 2025 | |||
| MAVERICK CAPITAL LTD | 8.5% | $8.9M | 10.2M | Maverick Capital, Ltd. | Jun 30, 2025 | |||
| M28 Capital Management LP | 4.6% | $8.31M | 9.55M | Marc Elia | Aug 22, 2025 | |||
| Polaris Venture Partners V, L.P. | 3% | $7.71M | 7.01M | Terrance McGuire | Aug 22, 2025 | |||
| FMR LLC | 4.8% | $3M | 5.78M | FMR LLC | Dec 31, 2024 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Change | Price | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 149M | $164M | +$101M | $1.10 | 76 |
| 2025 Q2 | 60.4M | $43.2M | -$6.83M | $0.72 | 65 |
| 2025 Q1 | 70.4M | $42.6M | -$3.65M | $0.61 | 80 |
| 2024 Q4 | 76.8M | $34M | -$5.34M | $0.44 | 74 |
| 2024 Q3 | 71.5M | $72.9M | -$4.77M | $1.02 | 75 |
| 2024 Q2 | 75.9M | $83.5M | -$14.4M | $1.10 | 81 |
| 2024 Q1 | 72.3M | $321M | +$73.1M | $4.44 | 84 |
| 2023 Q4 | 55.8M | $220M | +$10.2M | $3.94 | 59 |
| 2023 Q3 | 53.5M | $90.9M | -$3.86M | $1.70 | 56 |
| 2023 Q2 | 55.9M | $58.7M | -$4.3M | $1.05 | 55 |
| 2023 Q1 | 59.6M | $71.5M | +$82.8K | $1.20 | 69 |
| 2022 Q4 | 59.8M | $89.7M | -$6.22M | $1.50 | 79 |
| 2022 Q3 | 61.5M | $193M | +$3.49M | $3.13 | 68 |
| 2022 Q2 | 60.4M | $198M | +$1.53M | $3.28 | 67 |
| 2022 Q1 | 56.1M | $256M | -$37.3M | $4.56 | 68 |
| 2021 Q4 | 59.5M | $427M | -$11.3M | $7.26 | 75 |
| 2021 Q3 | 52.2M | $2.16B | +$2.16B | $42.24 | 66 |